Loading clinical trials...

A Global Registry on Second GEneration and Long-acting InTegrase InhibiTor FAilures | Clinical Trials | Clareo Health

Enrolling By InvitationNCT06706986

A Global Registry on Second GEneration and Long-acting InTegrase InhibiTor FAilures

Integrase strand transfer inhibitors (INSTI) inhibit HIV replication by preventing the integration of viral HIV DNA into the host's genome. INSTIs are used as part of combination antiretroviral therap...

Lead sponsor: UMC Utrecht•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

NCT07466836 · Human Immunodeficiency Virus (HIV)

RECRUITINGNA

Stress and Pain in People Living With HIV

NCT06784908 · HIV, Depression, and more

RECRUITINGPhase 2

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

NCT06749054 · HIV-1-infection

RECRUITING

Thinking and Memory Problems in People With HIV

NCT01875588 · HIV Positive

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 27, 2024Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment250

Start dateSep 2023

Last updatedNov 27, 2024

Condition

HIV Therapy Failure

Locations shown

University Medical Center Utrecht

Utrecht

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 27, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions